42
Views
1
CrossRef citations to date
0
Altmetric
Review

Body mass index and outcomes of endometrial and ovarian cancer patients

, , , &
Pages 221-229 | Received 16 Dec 2015, Accepted 25 Apr 2016, Published online: 24 May 2016

References

  • Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer J Int du Cancer. 2015;136(5):E359–E386. Epub 2014 Sep 16. doi:10.1002/ijc.29210.
  • Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer. 2013;49(6):1374–1403. Epub 2013 Mar 15. doi:10.1016/j.ejca.2012.12.027.
  • Ferlay JSI, Ervik M, Dikshit R, et al. GLOBOCAN 2012 v1.0, cancer incidence and mortality worldwide: IARC CancerBase no. 11 [Internet]. Lyon (France): International Agency for Research on Cancer; 2013 [cited 2015 Nov 27]. Available from: http://globocan.iarc.fr.
  • Cancer Research UK. Uterine cancer incidence statistics [Internet]. 2015 [updated 2015 Dec 13; cited 2015 Dec 7]. Available from: http://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/uterine-cancer/incidence
  • Cancer Research UK. Ovarian cancer incidence statistics [Internet]. 2015 [updated 2015 Nov 12; cited 2015 Dec 7]. Available from: http://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/ovarian-cancer/incidence
  • Health and Social Care Information Centre LST [Internet]. Statistics on obesity, physical activity and diet. 2015. [cited 2015 Dec 7]. Available from: http://www.hscic.gov.uk/catalogue/PUB16988/obes-phys-acti-diet-eng-2015.pdf
  • Wang YC, McPherson K, Marsh T, et al. Health and economic burden of the projected obesity trends in the USA and the UK. Lancet. 2011;378(9793):815–825. Epub 2011 Aug 30. doi:10.1016/S0140-6736(11)60814-3.
  • Arnold M, Pandeya N, Byrnes G, et al. Global burden of cancer attributable to high body-mass index in 2012: a population-based study. Lancet Oncol. 2015;16(1):36–46. Epub 2014 Dec 04. doi:10.1016/S1470-2045(14)71123-4.
  • Fader AN, Arriba LN, Frasure HE, et al. Endometrial cancer and obesity: epidemiology, biomarkers, prevention and survivorship. Gynecol Oncol. 2009;114(1):121–127. Epub 2009 May 02.
  • Leitzmann MF, Koebnick C, Danforth KN, et al. Body mass index and risk of ovarian cancer. Cancer. 2009;115(4):812–822. Epub 2009 Jan 08. doi:10.1002/cncr.24086.
  • Smits A, Lopes A, Bekkers R, et al. Body mass index and the quality of life of endometrial cancer survivors–a systematic review and meta-analysis. Gynecol Oncol. 2015;137(1):180–187. Epub 2015 Feb 01. doi:10.1016/j.ygyno.2015.01.540.
  • Bouwman F, Smits A, Lopes A, et al. The impact of BMI on surgical complications and outcomes in endometrial cancer surgery-an institutional study and systematic review of the literature. Gynecol Oncol. 2015;139(2):369–376. Epub 2015 Sep 27. doi:10.1016/j.ygyno.2015.09.020.
  • Smits A, Lopes A, Das N, et al. Surgical morbidity and clinical outcomes in ovarian cancer - the role of obesity. BJOG. 2015. ;123:300–308.
  • Colombo N, Preti E, Landoni F, et al. Endometrial cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2013;24 Suppl 6:vi33–38. Epub 2013 Oct 23.
  • Gunderson CC, Java J, Moore KN, et al. The impact of obesity on surgical staging, complications, and survival with uterine cancer: a gynecologic oncology group LAP2 ancillary data study. Gynecol Oncol. 2014;133(1):23–27. Epub 2014 Apr 01. doi:10.1016/j.ygyno.2014.01.041.
  • Giugale LE, Di Santo N, Smolkin ME, et al. Beyond mere obesity: effect of increasing obesity classifications on hysterectomy outcomes for uterine cancer/hyperplasia. Gynecol Oncol. 2012;127(2):326–331. Epub 2012 Aug 23. doi:10.1016/j.ygyno.2012.08.014.
  • Galaal K, Bryant A, Fisher AD, et al., Laparoscopy versus laparotomy for the management of early stage endometrial cancer. Cochrane Database Syst Rev. 2012;9:CD006655. Epub 2012 Sep 14.
  • Schwartz PE. Cytoreductive surgery in the management of ovarian cancer. Oncology. 2008;22(9):1025–1033; discussion 33–8, 41, 45. Epub 2008 Sep 10.
  • Tran A-Q, Cohen JG, Li AJ. Impact of obesity on secondary cytoreductive surgery and overall survival in women with recurrent ovarian cancer. Gynecol Oncol. 2015;138(2):263–266. Epub 2015 Jun 04. doi:10.1016/j.ygyno.2015.05.035.
  • Kumar A, Bakkum-Gamez JN, Weaver AL, et al. Impact of obesity on surgical and oncologic outcomes in ovarian cancer. Gynecol Oncol. 2014;135(1):19–24. Epub 2014 Aug 12. doi:10.1016/j.ygyno.2014.07.103.
  • Ledermann JA, Raja FA, Fotopoulou C, et al. Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2013;24 Suppl 6:vi24–32. Epub 2013 Oct 23. doi:10.1093/annonc/mdt333.
  • Moszyńska-Zielińska MC-FJ, Gottwald L, Żytko L, et al. Does obesity hinder radiotherapy in endometrial cancer patients? The implementation of new techniques in adjuvant radiotherapy - focus on obese patients. Prz Menopauzalny. 2014;18(2):96–100. Epub 2014 May 21.
  • Colombo N, Peiretti M, Garbi A, et al. Non-epithelial ovarian cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2012;23 Suppl 7:vii20–26. Epub 2012 Nov 20. doi:10.1093/annonc/mds223.
  • Al Asiri MTM, Rebman Alhaddab A, Mohammad R, et al. Impact of body mass index on treatment outcomes of adjuvant radiation therapy in saudi females with endometrial carcinoma. World J Surg Med Rad Oncol. 2012;1(22).
  • Bray TS, Kaczynski A, Albuquerque K, et al. Role of image guided radiation therapy in obese patients with gynecologic malignancies. Pract Radiat Oncol. 2013;3(4):249–255. Epub 2014 Mar 29. doi:10.1016/j.prro.2012.09.001.
  • Kim H, Beriwal S, Huq MS, et al. Evaluation of set-up uncertainties with daily kilovoltage image guidance in external beam radiation therapy for gynaecological cancers. Clin Oncol. 2012;24(2):e39–e45. Epub 2011 Sep 29. doi:10.1016/j.clon.2011.09.007.
  • Yavas G, Yavas C, Kerimoglu OS, et al. The impact of body mass index on radiotherapy technique in patients with early-stage endometrial cancer: a single-center dosimetric study. Int J Gynecol Cancer. 2014;24(9):1607–1615. Epub 2014 Oct 03. doi:10.1097/IGC.0000000000000298.
  • Sabater S, Arenas M, Berenguer R, et al. Body mass index and doses at organs at risk in a mediterranean population treated with postoperative vaginal cuff brachytherapy. Cancer Res Treat. 2015;47(3):473–479. Epub 2015 Feb 13. doi:10.4143/crt.2014.115.
  • Boyle JM, Craciunescu O, Steffey B, et al. Body mass index, dose to organs at risk during vaginal brachytherapy, and the role of three-dimensional CT-based treatment planning. Brachytherapy. 2014;13(4):332–336. Epub 2014 Jan 21. doi:10.1016/j.brachy.2013.12.002.
  • Martra F, Kunos C, Gibbons H, et al. Adjuvant treatment and survival in obese women with endometrial cancer: an international collaborative study. Am J Obstet Gynecol. 2008;198(1):89e1–8. Epub 2008 Jan 02. doi:10.1016/j.ajog.2007.06.023.
  • Dandapani SV, Zhang Y, Jennelle R, et al. Radiation-associated toxicities in obese women with endometrial cancer: more than just BMI? ScientificWorldJournal. 2015;2015:1–6. Epub 2015 Jul 07. doi:10.1155/2015/483208.
  • Von Gruenigen VE, Tian C, Frasure H, et al. Treatment effects, disease recurrence, and survival in obese women with early endometrial carcinoma: a Gynecologic Oncology Group study. Cancer. 2006;107(12):2786–2791. Epub 2006 Nov 11. doi:10.1002/cncr.22351.
  • Veldeman L, Madani I, Hulstaert F, et al. Evidence behind use of intensity-modulated radiotherapy: a systematic review of comparative clinical studies. Lancet Oncol. 2008;9(4):367–375. Epub 2008 Apr 01. doi:10.1016/S1470-2045(08)70098-6.
  • Mundt AJ, Lujan AE, Rotmensch J, et al. Intensity-modulated whole pelvic radiotherapy in women with gynecologic malignancies. Int J Radiat Oncol Biol Phys. 2002;52(5):1330–1337. Epub 2002 Apr 17.
  • Nevadunsky NS, Van Arsdale A, Strickler HD, et al. Obesity and age at diagnosis of endometrial cancer. Obstet Gynecol. 2014;124(2 Pt 1):300–306. Epub 2014 Jul 09. doi:10.1097/AOG.0000000000000381.
  • Modesitt SC, Tian C, Kryscio R, et al. Impact of body mass index on treatment outcomes in endometrial cancer patients receiving doxorubicin and cisplatin: a Gynecologic Oncology Group study. Gynecol Oncol. 2007;105(1):59–65. Epub 2006 Dec 08. doi:10.1016/j.ygyno.2006.10.045.
  • Au-Yeung G, Webb PM, DeFazio A, et al. Impact of obesity on chemotherapy dosing for women with advanced stage serous ovarian cancer in the Australian Ovarian Cancer Study (AOCS). Gynecol Oncol. 2014;133(1):16–22. Epub 2014 Apr 01. doi:10.1016/j.ygyno.2014.01.030.
  • Horowitz NS, Wright AA. Impact of obesity on chemotherapy management and outcomes in women with gynecologic malignancies. Gynecol Oncol. 2015;138(1):201–206. Epub 2015 Apr 15. doi:10.1016/j.ygyno.2015.04.002.
  • Barrett SV, Paul J, Hay A, et al. Does body mass index affect progression-free or overall survival in patients with ovarian cancer? Results from SCOTROC I trial. Ann Oncol. 2008;19(5):898–902. Epub 2008 Feb 15. doi:10.1093/annonc/mdm606.
  • Wright JD, Tian C, Mutch DG, et al. Carboplatin dosing in obese women with ovarian cancer: a Gynecologic Oncology Group study. Gynecol Oncol. 2008;109(3):353–358. Epub 2008 Apr 15. doi:10.1016/j.ygyno.2008.02.023.
  • Schwartz J, Toste B, Dizon DS. Chemotherapy toxicity in gynecologic cancer patients with a body surface area (BSA)>2 m2. Gynecol Oncol. 2009;114(1):53–56. Epub 2009 Apr 11. doi:10.1016/j.ygyno.2009.03.010.
  • Griggs JJ, Mangu PB, Anderson H, et al. Appropriate chemotherapy dosing for obese adult patients with cancer: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol. 2012;30(13):1553–1561. Epub 2012 Apr 05. doi:10.1200/JCO.2011.39.9436.
  • Lipscomb J, Gotay CC, Snyder CF. Patient-reported outcomes in cancer: a review of recent research and policy initiatives. CA Cancer J Clin. 2007;57(5):278–300. Epub 2007 Sep 15. doi:10.3322/CA.57.5.278.
  • Westin SN, Sun CC, Tung CS, et al. Survivors of gynecologic malignancies: impact of treatment on health and well-being. J Cancer Surviv. 2016;10(2):261–270.
  • Osoba D, Rodrigues G, Myles J, et al. Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol. 1998;16(1):139–144. Epub 1998 Jan 24.
  • King MT. The interpretation of scores from the EORTC quality of life questionnaire QLQ-C30. Qual Life Res. 1996;5(6):555–567. Epub 1996 Dec 01.
  • Von Gruenigen VE, Gil KM, Frasure HE, et al. The impact of obesity and age on quality of life in gynecologic surgery. Am J Obstet Gynecol. 2005;193(4):1369–1375. Epub 2005 Oct 06. doi:10.1016/j.ajog.2005.03.038.
  • Basen-Engquist K, Scruggs S, Jhingran A, et al. Physical activity and obesity in endometrial cancer survivors: associations with pain, fatigue, and physical functioning. Am J Obstet Gynecol. 2009;200(3):288e1–8. Epub 2008 Dec 27. doi:10.1016/j.ajog.2008.10.010.
  • Lin LL, Brown JC, Segal S, et al. Quality of life, body mass index, and physical activity among uterine cancer patients. Int J Gynecol Cancer. 2014;24(6):1027–1032. Epub 2014 Jun 14. doi:10.1097/IGC.0000000000000166.
  • Pekmezi DW, Demark-Wahnefried W. Updated evidence in support of diet and exercise interventions in cancer survivors. Acta Oncol. 2011;50(2):167–178. Epub 2010 Nov 26. doi:10.3109/0284186X.2010.529822.
  • Koutoukidis DA, Knobf MT, Lanceley A. Obesity, diet, physical activity, and health-related quality of life in endometrial cancer survivors. Nutr Rev. 2015;73(6):399–408. Epub 2015 May 27. doi:10.1093/nutrit/nuu063.
  • Smits A, Lopes A, Das N, et al. The impact of BMI on quality of life in obese endometrial cancer survivors: does size matter? Gynecol Oncol. 2014;132(1):137–141. Epub 2013 Nov 23. doi:10.1016/j.ygyno.2013.11.018.
  • Oldenburg CS, Boll D, Nicolaije KA, et al. The relationship of body mass index with quality of life among endometrial cancer survivors: a study from the population-based PROFILES registry. Gynecol Oncol. 2013;129(1):216–221. Epub 2013 Jan 09. doi:10.1016/j.ygyno.2012.12.041.
  • Luppino FS, de Wit LM, Bouvy PF, et al. Overweight, obesity, and depression: a systematic review and meta-analysis of longitudinal studies. Arch Gen Psychiatry. 2010;67(3):220–229. Epub 2010 Mar 03. doi:10.1001/archgenpsychiatry.2010.2.
  • Kolotkin RL, Zunker C, Ostbye T. Sexual functioning and obesity: a review. Obesity. 2012;20(12):2325–2333. Epub 2012 Apr 24. doi:10.1038/oby.2012.104.
  • Reeves GK, Pirie K, Beral V, et al. Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study. BMJ. 2007;335(7630):1134. Epub 2007 Nov 08. doi:10.1136/bmj.39367.495995.AE.
  • Smits A, Smits E, Lopes A, et al. Body mass index, physical activity and quality of life of ovarian cancer survivors: time to get moving? Gynecol Oncol. 2015;139(1):148–154. Epub 2015 Aug 21. doi:10.1016/j.ygyno.2015.08.005.
  • Smits A, Lopes A, Das N, et al. Quality of life in ovarian cancer survivors: the influence of obesity. Int J Gynecol Cancer. 2015;25(4):616–621. Epub 2015 Feb 11. doi:10.1097/IGC.0000000000000388.
  • Blanchard CM, Courneya KS, Stein K. American cancer society’s SCS, II. Cancer survivors’ adherence to lifestyle behavior recommendations and associations with health-related quality of life: results from the American Cancer Society’s SCS-II. J Clin Oncol. 2008;26(13):2198–2204. Epub 2008 May 01. doi:10.1200/JCO.2007.14.6217.
  • Blanchard CM, Stein K, Courneya KS. Body mass index, physical activity, and health-related quality of life in cancer survivors. Med Sci Sports Exerc. 2010;42(4):665–671. Epub 2009 Dec 03. doi:10.1249/MSS.0b013e3181bdc685.
  • Beesley VL, Price MA, Butow PN, et al. Physical activity in women with ovarian cancer and its association with decreased distress and improved quality of life. Psycho Oncol. 2011;20(11):1161–1169. Epub 2010 Aug 27. doi:10.1002/pon.1834.
  • Stevinson C, Faught W, Steed H, et al. Associations between physical activity and quality of life in ovarian cancer survivors. Gynecol Oncol. 2007;106(1):244–250. Epub 2007 May 12. doi:10.1016/j.ygyno.2007.03.033.
  • Vissers PA, Thong MS, Pouwer F, et al. The impact of comorbidity on health-related quality of life among cancer survivors: analyses of data from the PROFILES registry. J Cancer Surviv. 2013;7(4):602–613. Epub 2013 Aug 07. doi:10.1007/s11764-013-0299-1.
  • Teng FF, Kalloger SE, Brotto L, et al. Determinants of quality of life in ovarian cancer survivors: a pilot study. J Obstet Gynaecol Can. 2014;36(8):708–715. Epub 2014 Sep 16.
  • National Institutes of Health. Clinical guidelines on the identification, evaluation and treatment of overweight and obsity in adults - the evidence report. Obs Res. 1998;51S–209S.
  • Sikorski C, Luppa M, Kaiser M, et al. The stigma of obesity in the general public and its implications for public health - a systematic review. BMC Public Health. 2011;11:661. Epub 2011 Sep 24. doi:10.1186/1471-2458-11-661.
  • Puhl R, Brownell KD. Bias, discrimination, and obesity. Obes Res. 2001;9(12):788–805. Epub 2001 Dec 18. doi:10.1038/oby.2001.108.
  • Doll KM, Kalinowski AK, Snavely AC, et al. Obesity is associated with worse quality of life in women with gynecologic malignancies: an opportunity to improve patient-centered outcomes. Cancer. 2015;121(3):395–402. Epub 2014 Sep 25. doi:10.1002/cncr.29061.
  • Baker J, Janda M, Gebski V, et al. Lower preoperative quality of life increases postoperative risk of adverse events in women with endometrial cancer: results from the LACE trial. Gynecol Oncol. 2015;137(1):102–105. Epub 2015 Feb 17. doi:10.1016/j.ygyno.2015.02.008.
  • Doll KM, Snavely AC, Kalinowski A, et al. Preoperative quality of life and surgical outcomes in gynecologic oncology patients: a new predictor of operative risk? Gynecol Oncol. 2014;133(3):546–551. Epub 2014 Apr 15. doi:10.1016/j.ygyno.2014.04.002.
  • Wenzel L, Huang HQ, Monk BJ, et al. Quality-of-life comparisons in a randomized trial of interval secondary cytoreduction in advanced ovarian carcinoma: a Gynecologic Oncology Group study. J Clin Oncol. 2005;23(24):5605–5612. Epub 2005 Aug 20. doi:10.1200/JCO.2005.08.147.
  • Von Gruenigen VE, Huang HQ, Gil KM, et al. The association between quality of life domains and overall survival in ovarian cancer patients during adjuvant chemotherapy: a Gynecologic Oncology Group study. Gynecol Oncol. 2012;124(3):379–382. Epub 2011 Nov 29. doi:10.1016/j.ygyno.2011.11.032.
  • Cancer Research UK. Cancer survival for common cancers. 2015 [updated 2014 Apr 29; cited 2015 Nov 27]. Available from: http://www.cancerresearchuk.org/health-professional/cancer-statistics/survival/common-cancers-compared.
  • Adams KF, Schatzkin A, Harris TB, et al. Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old. N Engl J Med. 2006;355(8):763–778. Epub 2006 Aug 24. doi:10.1056/NEJMoa055643.
  • Calle EE, Thun MJ, Petrelli JM, et al. Body-mass index and mortality in a prospective cohort of U.S. adults. N Engl J Med. 1999;341(15):1097–1105. Epub 1999Oct 08. doi:10.1056/NEJM199910073411501.
  • Secord AA, Hasselblad V, Von Gruenigen VE, et al. Body mass index and mortality in endometrial cancer: a systematic review and meta-analysis. Gynecol Oncol. 2016;140(1):184–190.
  • Lindemann K, Cvancarova M, Eskild A. Body mass index, diabetes and survival after diagnosis of endometrial cancer: a report from the HUNT-survey. Gynecol Oncol. 2015. Epub 2015 Oct 06. doi:10.1016/j.ygyno.2015.09.088.
  • Arem H, Irwin ML. Obesity and endometrial cancer survival: a systematic review. Int J Obes. 2013;37(5):634–639. Epub 2012 Jun 20. doi:10.1038/ijo.2012.94.
  • Arem H, Park Y, Pelser C, et al. Prediagnosis body mass index, physical activity, and mortality in endometrial cancer patients. J Natl Cancer Inst. 2013;105(5):342–349. Epub 2013 Jan 09. doi:10.1093/jnci/djs530.
  • Arem H, Chlebowski R, Stefanick ML, et al. Body mass index, physical activity, and survival after endometrial cancer diagnosis: results from the women’s health initiative. Gynecol Oncol. 2013;128(2):181–186. Epub 2012 Nov 07. doi:10.1016/j.ygyno.2012.10.029.
  • Bae HS, Kim HJ, Hong JH, et al. Obesity and epithelial ovarian cancer survival: a systematic review and meta-analysis. J Ovarian Res. 2014;7:41. Epub 2014 May 17. doi:10.1186/1757-2215-7-41.
  • Protani MM, Nagle CM, Webb PM. Obesity and ovarian cancer survival: a systematic review and meta-analysis. Cancer Prev Res. 2012;5(7):901–910. Epub 2012 May 23.
  • Barakat RRBA, Markman M, Randall ME. Principles and practise of gynecologic oncology. 6th ed. RR B, editor. Philadelphia (PA): Lippincott Williams & Williams, Wolters Kluwer; 2013.
  • Zhou Y, Chlebowski R, LaMonte MJ, et al. Body mass index, physical activity, and mortality in women diagnosed with ovarian cancer: results from the women’s health initiative. Gynecol Oncol. 2014;133(1):4–10. Epub 2014 Apr 01.
  • Stalberg K, Svensson T, Lonn S, et al. The influence of comorbidity on mortality in ovarian cancer patients. Gynecol Oncol. 2014;133(2):298–303. Epub 2014 Mar 04.
  • Ward KK, Shah NR, Saenz CC, et al. Cardiovascular disease is the leading cause of death among endometrial cancer patients. Gynecol Oncol. 2012;126(2):176–179. Epub 2012 Apr 18.
  • Dinkelspiel HE, Champer M, Hou J, et al. Long-term mortality among women with epithelial ovarian cancer. Gynecol Oncol. 2015;138(2):421–428. Epub 2015 Jun 09.
  • Wild SH, Bryden JR, Lee RJ, et al. Cancer, cardiovascular disease and diabetes mortality among women with a history of endometrial cancer. Br J Cancer. 2007;96(11):1747–1749. Epub 2007 Apr 25.
  • Nicholas Z, Hu N, Ying J, et al. Impact of comorbid conditions on survival in endometrial cancer. Am J Clin Oncol. 2014;37(2):131–134. Epub 2012 Dec 18.
  • Calle EE, Kaaks R. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer. 2004;4(8):579–591. Epub 2004 Aug 03.
  • Mishra SI, Scherer RW, Snyder C, et al., Exercise interventions on health-related quality of life for people with cancer during active treatment. Cochrane Database Syst Rev. 2012;8:CD008465. Epub 2012 Aug 17.
  • Mishra SI, Scherer RW, Geigle PM, et al. Exercise interventions on health-related quality of life for cancer survivors. Cochrane Database Syst Rev. 2012;8:CD007566. Epub 2012 Aug 17.
  • Smits A, Lopes A, Das N, et al. The effect of lifestyle interventions on the quality of life of gynaecological cancer survivors: a systematic review and meta-analysis. Gynecol Oncol. 2015;139(3):546–552.
  • Donnelly CM, Blaney JM, Lowe-Strong A, et al. A randomised controlled trial testing the feasibility and efficacy of a physical activity behavioural change intervention in managing fatigue with gynaecological cancer survivors. Gynecol Oncol. 2011;122(3):618–624. Epub 2011 Jun 22.
  • McCarroll ML, Armbruster S, Frasure HE, et al. Self-efficacy, quality of life, and weight loss in overweight/obese endometrial cancer survivors (SUCCEED): a randomized controlled trial. Gynecol Oncol. 2014;132(2):397–402. Epub 2013 Dec 27.
  • Von Gruenigen VE, Gibbons HE, Kavanagh MB, et al., A randomized trial of a lifestyle intervention in obese endometrial cancer survivors: quality of life outcomes and mediators of behavior change. Health Qual Life Outcomes. 2009;7:17. Epub 2009 Feb 27.
  • Paxton RJ, Garcia-Prieto C, Berglund M, et al. A randomized parallel-group dietary study for stages II-IV ovarian cancer survivors. Gynecol Oncol. 2012;124(3):410–416. Epub 2011 Nov 29.
  • Hwang KH, Cho OH, Yoo YS. The effect of comprehensive care program for ovarian cancer survivors. Clin Nurs Res. 2016;25(2):192–208.
  • Moonsammy SH, Guglietti CL, Santa Mina D, et al. A pilot study of an exercise & cognitive behavioral therapy intervention for epithelial ovarian cancer patients. J Ovarian Res. 2013;6(1):21. Epub 2013 Apr 06.
  • Newton MJ, Hayes SC, Janda M, et al. Safety, feasibility and effects of an individualised walking intervention for women undergoing chemotherapy for ovarian cancer: a pilot study. BMC Cancer. 2011;11:389. Epub 2011 Sep 09. doi:10.1186/1471-2407-11-389.
  • Von Gruenigen VE, Frasure HE, Kavanagh MB, et al. Feasibility of a lifestyle intervention for ovarian cancer patients receiving adjuvant chemotherapy. Gynecol Oncol. 2011;122(2):328–333. Epub 2011 May 24. doi:10.1016/j.ygyno.2011.04.043.
  • Salani R. Survivorship planning in gynecologic cancer patients. Gynecol Oncol. 2013;130(2):389–397. Epub 2013 May 28. doi:10.1016/j.ygyno.2013.05.022.
  • Schmid D, Leitzmann MF. Association between physical activity and mortality among breast cancer and colorectal cancer survivors: a systematic review and meta-analysis. Ann Oncol. 2014;25(7):1293–1311. Epub 2014 Mar 20. doi:10.1093/annonc/mdu012.
  • U.S. National Institutes of Health. ClinicalTrials.gov. 2015 [cited 2015 Nov 10]. Available from: https://clinicaltrials.gov/.
  • Von Gruenigen VE, Waggoner SE, Frasure HE, et al. Lifestyle challenges in endometrial cancer survivorship. Obstet Gynecol. 2011;117(1):93–100. Epub 2010 Dec 22. doi:10.1097/AOG.0b013e31820205b3.
  • Beesley VL, Eakin EG, Janda M, et al. Gynecological cancer survivors’ health behaviors and their associations with quality of life. Cancer Causes Control. 2008;19(7):775–782. Epub 2008 Mar 07. doi:10.1007/s10552-008-9140-y.
  • Tseng JH, Roche KL, Jernigan AM, et al. Lifestyle and weight management counseling in uterine cancer survivors: a study of the uterine cancer action network. Int J Gynecol Cancer. 2015;25(7):1285–1291. Epub 2015 May 15. doi:10.1097/IGC.0000000000000475.
  • Jernigan AM, Tergas AI, Satin AJ, et al. Obesity management in gynecologic cancer survivors: provider practices and attitudes. Am J Obstet Gynecol. 2013;208(5):408e1–8. Epub 2013 Feb 12. doi:10.1016/j.ajog.2013.02.002.
  • Neff R, McCann GA, Carpenter KM, et al. Is bariatric surgery an option for women with gynecologic cancer? Examining weight loss counseling practices and training among gynecologic oncology providers. Gynecol Oncol. 2014;134(3):540–545. Epub 2014 Jun 17. doi:10.1016/j.ygyno.2014.06.006.
  • Demark-Wahnefried W, Aziz NM, Rowland JH, et al. Riding the crest of the teachable moment: promoting long-term health after the diagnosis of cancer. J Clin Oncol. 2005;23(24):5814–5830. Epub 2005 Jul 27. doi:10.1200/JCO.2005.01.230.
  • Stull VB, Snyder DC, Demark-Wahnefried W. Lifestyle interventions in cancer survivors: designing programs that meet the needs of this vulnerable and growing population. J Nutr. 2007;137(1 Suppl):243S–8S. Epub 2006 Dec 22.
  • McCarroll ML, Armbruster S, Pohle-Krauza RJ, et al. Feasibility of a lifestyle intervention for overweight/obese endometrial and breast cancer survivors using an interactive mobile application. Gynecol Oncol. 2015;137(3):508–515. Epub 2015Feb 15. doi:10.1016/j.ygyno.2014.12.025.
  • Sabesan S, Burgher B, Buettner P, et al. Attitudes, knowledge and barriers to participation in cancer clinical trials among rural and remote patients. Asia Pac J Clin Oncol. 2011;7(1):27–33. Epub 2011 Feb 22. doi:10.1111/j.1743-7563.2010.01342.x.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.